Corplex™ is a dehydrated human umbilical cord tissue allograft intended for use as a wound covering over chronic and acute wounds. Provides a thick wound care option that retains both the epithelial layer and the Wharton's Jelly of the native umbilical cord in a shelf-stable format.
• Retains key extracellular matrix components, including collagens, proteoglycans, and glycosaminoglycans.
• Sheet is processed using the Clearify™ process to maximize the retention of these desired structural components, while effectively cleaning and terminally sterilizing the graft
• Retention of these desired structural components in Corplex™ results in a thick structural matrix optimized for use as a barrier membrane and/or wound covering for deep wounds
Corplex™ is intended for homologous use for the repair, reconstruction, replacement, or supplementation of a recipient's tissue; specifically, the product is intended for use as a wound covering or barrier membrane over chronic and acute wounds, including dermal ulcers or defects.
Do not use Corplex™ on any wound with evidence of active, latent infection, or gangrene. Do not use Corplex™ on compromised patients where the patient's condition may create an unacceptable risk of post-operative infection or complications.
No current Adverse Effects or Reactions attributed to the Corplex™ allograft.
The Corplex™ allograft should be maintained in its original packaging and stored at ambient temperature (0°C-38°C) until ready for use. When stored properly in their original packaging, Corplex™ allografts are shelf-stable for up to five years.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years||●|
|Shelf life limited||●|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Remove Corplex™ from the sterile packaging by peeling open the outer peel pouch using the chevron opening. Present the inner, sterile peel pouch into the sterile field. Peel open the sterile pouch and aseptically extract the membrane from the package. Corplex™ may be applied over the wound area either wet or dry. If rehydration is desired, apply several drops of sterile saline solution at one- to two-minute intervals until the desired level of rehydration is achieved. Apply Corplex™ directly to the prepared wound bed, ensuring contact with the wound bed. To discourage allograft displacement following transplantation, Corplex™ may be affixed to the surgical site using aseptic technique with a variety of wound closure mechanisms including absorbable sutures, non-absorbable sutures, and/or tissue adhesive appropriate for the wound type.
StimLabs, LLC is a leader in regenerative technologies, with an extensive product pipeline, a portfolio of intellectual property and a suite of placental-derived products.